yep its a pretty interesting biotech. not many biotech have a product that is natural and also proven to work. there is much less risk investing in biotech's with proven products. Product was used in the 1990s, but due to ownership and change of control from the distributor, the product went out of use. very low market cap, so leveraged to any revenues/profits they can get from this product basically. health considerations around the antibiotic free meat, provide the investment thesis.
There is also other animal potential, and human partnership potential of course. it lists on monday.
- Forums
- IPOs
- The answer is a Pineapple
yep its a pretty interesting biotech. not many biotech have a...
Featured News
Featured News
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online